Skip to content
Precision for Medicine
Contact Us
image 35

Meet Our Precision for Medicine Leadership Teams

We believe an essential element in the success of your project will be the experience of our people
Here are our leaders and experts. Our experience runs as deep as our passion for patients. We are multi-faceted in our breadth of knowledge and collaborate as one team, across functions, to fit the needs of your project. With specialized expertise in the development of complex therapies, we are ready to go to work for you.

Meet our Precision for Medicine Leadership

    • Chad_Clark_Resize
                 

      Chad Clark

      President and Chief Operating Officer, Precision Medicine Group

    • Sofia_Baig
                 

      Sofia Baig

      President, Precision for Medicine

    • Daisy-DeWeese-Gatt
                 

      Daisy DeWeese-Gatt, MPH

      President, Clinical Solutions

    • Matt Grow 1
                 

      Matt Grow

      Chief Commercial Officer

    • Deb Phippard
                 

      Deborah Phippard, PhD

      Chief Scientific Officer

    • Harpreet-Singh2
                 

      Harpreet Singh, MD

      Chief Medical Officer

    • Daisy-DeWeese-Gatt
                 

      Daisy DeWeese-Gatt, MPH

      President

    • Harpreet-Singh2
                 

      Harpreet Singh, MD

      Chief Medical Officer

    • Nithiyanandhan-Ananthakrishnan-1
                 

      Nithiya Ananthakrishnan

      Senior Vice President, Biometrics

    • Joy Carson
                 

      Joy Carson

      Vice President, Operational Strategy

    • James Cheong
                 

      James Cheong

      Senior Vice President, Asia Pacific, Clinical Solutions​

    • Andrea Cotton
                 

      Andrea Cotton-Berry

      Global Head of Strategic Development

    • Simon-Fleming
                 

      Simon Fleming

      Executive Vice President

    • Nicholas Richardson
                 

      Nicholas Richardson, DO, MPH

      Vice President, Clinical Development

    • Anoop Santhosh
                 

      Anoop Santhosh

      Vice President and Head of India

    • SallyAnne Williams
                 

      Sallyanne Williams

      Executive Vice President, Global Head Project Management

    • Jing Ping Yeo
                 

      Jing Ping Yeo, PhD

      Vice President, Clinical Operations, Head of Asia Pacific​

    • Deb Phippard
                 

      Deborah Phippard, PhD

      Chief Scientific Officer

    • YvoneBeasly
                 

      Yvonne Beasley

      Vice President, Global Central Lab Services

    • Darren Davis
                 

      Darren Davis, PhD

      Senior Vice President, Translational Sciences

    • Rob Fannon Headshot
                 

      Rob Fannon, MPH, MBA

      General Manager, Biospecimen Solutions

    • Sven Olek
                 

      Sven Olek, PhD

      Senior Vice President, Research

Chad_Clark_Resize
Chad Clark

President and Chief Operating Officer, Precision Medicine Group

Recognized industry leader with deep expertise spanning biomarker-driven clinical development, patient access and global market access. In addition to the role at Precision Medicine Group, Chad is also President of Precision for Medicine. In prior roles he has served as Chief Operating Officer of United BioSource Corporation and founder of DataPhaseIV. Proven ability to scale operations in response to client needs, adding the end-to-end capabilities necessary to support development and patient access to today’s complex therapies.
   
Sofia_Baig
Sofia Baig

President, Precision for Medicine

Exceptional strategic leader, adept at driving organizational change and delivering top- and bottom-line business growth. Expert in strategic account management, global clinical development operations, and delivering transformational change inclusive of people, processes, and technology. Winner of multiple prestigious awards, including PharmaVoice 100 most inspiring leader in the life sciences industry, and as part of a team, the Catalyst Award for DEI work focused on improving women’s representation in senior leadership.
   
Daisy-DeWeese-Gatt
Daisy DeWeese-Gatt, MPH

President, Clinical Solutions

Industry veteran with over 25 years’ experience working across all phases of global drug development and leading large international teams, most recently at ICON Biotech and a team of 3,000 people across 45 countries. Passionate about driving breakthroughs in treatment for oncology and rare diseases. Prior roles include senior leadership positions at IQVIA Biotech and PPD. Proven ability to lead operational excellence and deliver results for oncology innovators. Maintains a part-time faculty role at the University of North Carolina Wilmington.
   
Matt Grow 1
Matt Grow

Chief Commercial Officer

Visionary leader with a strong track record of fostering growth through commercial innovation and excellence. Drives sales by evolving the go-to-market model, landing and expanding key customer segments, and strengthening active client relationships. Proven expertise in biotech and pharmaceutical development spanning executive management, strategy, business development, sales, marketing and account management.
   
Deb Phippard
Deborah Phippard, PhD

Chief Scientific Officer

Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.
   
Harpreet-Singh2
Harpreet Singh, MD

Chief Medical Officer

Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors.
   
Daisy-DeWeese-Gatt
Daisy DeWeese-Gatt, MPH

President

Industry veteran with over 25 years’ experience working across all phases of global drug development and leading large international teams, most recently at ICON Biotech and a team of 3,000 people across 45 countries. Passionate about driving breakthroughs in treatment for oncology and rare diseases. Prior roles include senior leadership positions at IQVIA Biotech and PPD. Proven ability to lead operational excellence and deliver results for oncology innovators. Maintains a part-time faculty role at the University of North Carolina Wilmington.
   
Harpreet-Singh2
Harpreet Singh, MD

Chief Medical Officer

Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors.
   
Nithiyanandhan-Ananthakrishnan-1
Nithiya Ananthakrishnan

Senior Vice President, Biometrics

Visionary executive with a distinguished track-record fostering an environment of continuous innovation and growth through people-centric strategies. Data sciences leader focused on data analysis, visualization, and solutions to solve key issues in clinical trials. On a personal level, deeply committed to supporting educational excellence, particularly for underprivileged children.
   
Joy Carson
Joy Carson

Vice President, Operational Strategy

Industry veteran with more than 30 years of global experience in clinical research across academia, sponsors, government programs, and CROs. Expertise in designing and managing Phase 1–4 drug and diagnostic trials, portfolio governance, project leader mentoring, and financial oversight. Proven leadership in oncology, infectious, neurodegenerative, and rare diseases. Strong track record in building multidisciplinary teams and engaging with key opinion leaders and advocacy groups. Experienced in pharmaceutical, biologic, device, gene therapy, and marketing trials, with IND, NDA, PMA, and 510(k) submission experience.
   
James Cheong
James Cheong

Senior Vice President, Asia Pacific, Clinical Solutions​

An industry veteran with nearly three decades of experience in the clinical research industry and deep expertise in clinical operations and strategic leadership across both pharmaceutical and CRO environments. Held pivotal roles as Head of Clinical Operations for Greater China at Boehringer Ingelheim, leading trials in oncology, respiratory, stroke, and cardio-metabolic diseases and CEO of George Clinical, a global CRO with strong scientific capabilities in renal and oncology therapeutic areas. At Precision for Medicine, a leader for business strategy across the Asia Pacific region. Focused on driving regional growth, building strategic partnerships, and supporting excellence in portfolio delivery and client satisfaction. An acknowledged driver of precision-driven solutions that improve patient outcomes.
   
Andrea Cotton
Andrea Cotton-Berry

Global Head of Strategic Development

Notable authority in global operations, dedicated to fostering team spirit of excellence and collaboration with internal and external partners. Veteran of the quest to improve oncology therapies and extend lives, including 15+ years in oncology drug development, building on 10 years in obstetrics and women’s health.
   
Simon-Fleming
Simon Fleming

Executive Vice President

Veteran of the pharmaceutical industry, fluent in all aspects of clinical trial management, including business development, strategic operations, process improvement, technology implementation and finance. Special focus on global quality management, data management, biostatistics and statistical programming operations.
   
Nicholas Richardson
Nicholas Richardson, DO, MPH

Vice President, Clinical Development

An expert in hematology and oncology and a veteran of the FDA with almost nine years of experience, culminating as a Deputy Director for the Division of Hematologic Malignancies 2. Possesses a profound understanding of regulatory strategy, particularly in the development of CAR-T cell therapies, bispecifics and T-cell engagers. Spearheaded initiatives to develop novel endpoints in blood cancer such as minimal residual disease (MRD) in lymphoma and chronic lymphocytic leukemia (CLL.)
   
Anoop Santhosh
Anoop Santhosh

Vice President and Head of India

With 20 years of experience across technology, operations, and regulated service environments, Anoop brings deep expertise in strategic operations, organizational scaling, and operational excellence. His leadership experience spans global, data‑driven CRO and technology organizations, where he has overseen complex, cross‑functional teams and enterprise operations. Based in Bengaluru, India, he holds a great track record for his structured, people‑focused leadership style and passion for building high‑performance teams, driving continuous improvement, and enabling sustainable growth in regulated, global environments.
   
SallyAnne Williams
Sallyanne Williams

Executive Vice President, Global Head Project Management

Long-standing project management leader dedicated to improving delivery across all phases of product development. Working on a global scale, applies strategic smarts to operational delivery and financial management. Recognized as one of the PharmaVoice 100, some of the industry’s most inspiring people, awarded in the “Change Agent” category.
   
Jing Ping Yeo
Jing Ping Yeo, PhD

Vice President, Clinical Operations, Head of Asia Pacific​

Highly accomplished global clinical operations executive with nearly three decades of experience providing strategic leadership, regional expansion, and operational excellence across Asia Pacific. Brings deep expertise across clinical development, project and portfolio operations, biometrics, regulatory affairs, safety and pharmacovigilance, quality management, and financial governance. Proven builder and scaler of high‑performing teams and start‑up operations in both regional and global environments. Recognized industry leader who actively contributes to advancing clinical research standards through advisory and governance roles across Asia.
   
Deb Phippard
Deborah Phippard, PhD

Chief Scientific Officer

Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.
   
YvoneBeasly
Yvonne Beasley

Vice President, Global Central Lab Services

Trusted industry leader with extensive experience in end-to-end biospecimen operational management, developing and leading operational teams of all sizes across multiple labs on a global scale. Deep knowledge of regulatory requirements. Delivery of operational excellence ensuring standardized processes and reliable and secure procedures for quality and efficiency.
   
Darren Davis
Darren Davis, PhD

Senior Vice President, Translational Sciences

Visionary leader with decades of distinguished biotechnology and clinical translational research experience. Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dedicated and committed to improving the lives of patients with debilitating diseases.
   
Rob Fannon Headshot
Rob Fannon, MPH, MBA

General Manager, Biospecimen Solutions

Respected veteran of the biospecimen and biomarker laboratory services industry. Honed his expertise through leadership roles in organizations including Roche, Cancer Genetics, and BioServe. Holds a Master of Public Health and a Masters of Business Administration from the Johns Hopkins University.
   
Sven Olek
Sven Olek, PhD

Senior Vice President, Research

Inventor, industry expert, founder and leader of Epiontis. Developed the patents forming the basis of Epiontis’s intellectual property. Conducted pre- and postdoctoral research at the Center for Molecular Biology and Biomedicine (ZMBH) of the University of Heidelberg, Germany and the R.W. Johnson Pharmaceutical Research Institute, San Diego, California, USA. Received a BSc from the Imperial College of Science, Technology, and Medicine, London, and a PhD in Biochemistry from the University of London.